Pradaxa

Pradaxa Description

dabigatran

Manufacturer:

Boehringer Ingelheim

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Each 75-, 110- and 150 mg cap contains β-alanine, N-[[2-[[[4(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester, methane-sulfonate, being the methane sulfonic acid salt 86.48 mg, 126.83 mg or 172.95 mg corresponding to dabigatran etexilate base form 75 mg, 110 mg or 150 mg, respectively.
It also contains the following excipients: Tartaric acid, acacia, hypromellose, dimethicone 350, talc, hydroxypropyl cellulose. HPMC Capsule Shell: Carragenan, potassium chloride, titanium dioxide, sunset yellow (E110), indigo carmine (E132), hypromellose. Printing Ink: Shellac, N-butyl alcohol, isopropyl alcohol, industrial methylated spirit, black iron oxide (E172), purified water, propylene glycol.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in